-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SF2dpOu6gWNR9Tw3TRlMZkUp/tj2w+qK2+oKZiuga6xtX6AtHyZxYoUUkrAIJomS OUjB3wT06eFcNNbaKBOk/w== 0000950124-01-000055.txt : 20010122 0000950124-01-000055.hdr.sgml : 20010122 ACCESSION NUMBER: 0000950124-01-000055 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20010105 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEDTOX SCIENTIFIC INC CENTRAL INDEX KEY: 0000739944 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 953863205 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-37329 FILM NUMBER: 1502899 BUSINESS ADDRESS: STREET 1: 402 WEST COUNTY ROAD D CITY: ST PAUL STATE: MN ZIP: 55112 BUSINESS PHONE: 6126367466 MAIL ADDRESS: STREET 1: 402 WEST COUNTY ROAD D CITY: ST PAUL STATE: MN ZIP: 55112 FORMER COMPANY: FORMER CONFORMED NAME: EDITEK INC DATE OF NAME CHANGE: 19940902 FORMER COMPANY: FORMER CONFORMED NAME: ENVIRONMENTAL DIAGNOSTICS INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PYRAMID TRADING LTD PARTNERSHIP /IL CENTRAL INDEX KEY: 0001107219 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 363723624 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 440 SO LASALLE ST SUITE 700 CITY: CHICAGO STATE: IL ZIP: 60605 BUSINESS PHONE: 3123624000 MAIL ADDRESS: STREET 1: 440 SO LASALLE ST SUITE 700 CITY: CHICAGO STATE: IL ZIP: 60605 SC 13D/A 1 c59450a1sc13da.txt AMENDMENT #1 TO SCHEDULE 13D 1 SCHEDULE 13D (RULE 13d-101) Information to be Included in Statements Filed Pursuant to Rule 13d-1(a) and Amendments Thereto Filed Pursuant to Rule 13d-2(a) SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Amendment No. 1 to SCHEDULE 13D Under the Securities Exchange Act of 1934 Medtox Scientific, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock and Warrants - -------------------------------------------------------------------------------- (Title of Class of Securities) 586999-40-1 - -------------------------------------------------------------------------------- (CUSIP Number) Robert T. Montague Robins, Kaplan, Miller & Ciresi 800 LaSalle Avenue, Suite 2800 Minneapolis, MN 55408 612-349-8500 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 27, 2000 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box / /. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 2 CUSIP NO. 586999-40-1 13D PAGE 2 OF 9 PAGES - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Pyramid Trading Limited Partnership 36-3723624 - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See Instructions) WC - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Illinois - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF 0 Shares SHARES ----------------------------------------------------------------- 8 SHARED VOTING POWER BENEFICIALLY 348,300 Shares OWNED BY EACH ----------------------------------------------------------------- 9 SOLE DISPOSITIVE POWER REPORTING 0 Shares PERSON ----------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER WITH 348,300 Shares - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 348,300 Shares - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.5% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See Instructions) BD, PN, IV - -------------------------------------------------------------------------------- 3 CUSIP NO. 586999-40-1 13D PAGE 3 OF 9 PAGES - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Oakmont Investments, LLC 36-3996171 - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See Instructions) N/A - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Illinois - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF 0 Shares SHARES ----------------------------------------------------------------- 8 SHARED VOTING POWER BENEFICIALLY 348,300 Shares OWNED BY EACH ----------------------------------------------------------------- 9 SOLE DISPOSITIVE POWER REPORTING 0 Shares PERSON ----------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER WITH 348,300 Shares - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 348,300 Shares - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.5% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See Instructions) CO, IV - -------------------------------------------------------------------------------- 4 CUSIP NO. 5869999-40-1 13D PAGE 4 OF 9 PAGES - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Daniel Asher, ###-##-#### - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See Instructions) N/A - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF 348,300 Shares SHARES ----------------------------------------------------------------- 8 SHARED VOTING POWER BENEFICIALLY 348,300 Shares OWNED BY EACH ----------------------------------------------------------------- 9 SOLE DISPOSITIVE POWER REPORTING 348,300 Shares PERSON ----------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER WITH 348,300 Shares - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 348,300 Shares - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.5% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See Instructions) - -------------------------------------------------------------------------------- 5 5 of 9 CUSIP No.586999-40-1 This Amendment No. 1 ("Amendment No. 1") amends the Statement on Schedule 13D (the "Schedule 13D") filed on September 28, 2000, by Pyramid Trading Limited Partnership ("PT"), Oakmont Investments, LLC, the general partner of PT ("OI") and Daniel Asher, as manager of OI and individually ("DA") (collectively the "Reporting Persons") with respect to their beneficial ownership of common stock, par value $.15 per share (the "Common Stock") of Medtox Scientific, Inc., a Delaware corporation (the "Company"). The principal executive offices of the Company are located at 402 West County Road D, St. Paul, MN 55112. Item 5 is hereby amended to read as follows: 6 6 of 9 CUSIP No.586999-40-1 ITEM 5. INTEREST IN SECURITIES OF THE ISSUER (a) As of 12/27/00 the Reporting Persons beneficially owned the amounts of Common Stock and Warrant to purchase Common Stock respectively set forth below. The percentage set forth below represents the percentage of the outstanding shares of Common Stock based on 3,506,716 shares outstanding as of 11/13/00 as set forth in the Company's Form 10Q for the quarter ended 09/30/00 as adjusted in accordance with Rule 13D-3.
Reporting Shares of Percent of Person Common Stock Outstanding Common Stock - --------- ------------ ------------------------ PT, OI, DA 348,300(1) 9.5
- ---------------- 1 Includes Warrants to purchase 140,000 shares exercisable within (sixty) 60 days. (b) The information set forth in Items 7 through 11 of the cover pages hereto is incorporated herein by reference. (c) The following schedule sets forth all transactions (open market purchases) in the Common Stock of the Company effected by the Reporting Persons since the filing of the Schedule 13D: Date of Purchase No. of Shares Price Per Share (net of commissions) - ---------------- ------------- ------------------------------------ 10/05/00 500 10.63 10/24/00 600 11.00 10/25/00 1,100 11.00 10/27/00 500 11.75 10/27/00 9,000 12.00 10/27/00 500 12.13 10/27/00 2,000 12.25 10/30/00 3,000 12.13 11/01/00 1,300 12.00 11/02/00 200 11.88 11/03/00 1,800 11.75 11/22/00 8,000 11.63 11/27/00 3,400 11.50 11/29/00 2,300 11.00 12/04/00 1,000 9.38 12/04/00 2,000 9.50 12/15/00 6,500 7.88 12/18/00 4,000 7.75 12/20/00 5,000 6.88 12/21/00 5,000 6.25 12/21/00 5,000 6.75 12/21/00 5,000 6.88 12/27/00 600 5.75 7 7 of 9 CUSIP No.586999-40-1 ITEM 7. MATERIAL TO BE FILED AS EXHIBITS 1. Agreement dated as of January 4, 2001 by and among the signatories of this Statement on Schedule 13D with respect to its filing. SIGNATURE After reasonable inquiry and to the best of his knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: January 4, 2001 PYRAMID TRADING LIMITED PARTNERSHIP BY: OAKMONT INVESTMENTS, LLC ITS: GENERAL PARTNER BY: /S/ Daniel Asher ------------------------------- Daniel Asher Manager, Oakmont Investments, LLC OAKMONT INVESTMENTS, LLC BY: /S/ Daniel Asher ------------------------------- Daniel Asher, Manager /s/ Daniel Asher ----------------------------------- DANIEL ASHER 8 8 of 9 CUSIP No.586999-40-1 EXHIBIT INDEX EXHIBIT NO. DOCUMENT 1 Agreement, dated as of January 4, 2001 by and among the signatories of this Statement with respect to its filing. TYPE: EX-1 SEQUENCE: 2 DESCRIPTION: AGREEMENT DATED AS OF JANUARY 4, 2001 EX-1 2 c59450a1ex1.txt AGREEMENT, DATED AS OF JANUARY 4, 2001 1 CUSIP No.586999-40-1 EXHIBIT 1 AGREEMENT This will confirm the agreement by and among all the undersigned that the Amendment No. 1 to Schedule 13D filed on or about this date with respect to the beneficial ownership of the undersigned of shares of Common Stock of Medtox Scientific, Inc. is being filed on behalf of each of the signatories names below. This agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Date: January 4, 2001 PYRAMID TRADING LIMITED PARTNERSHIP BY: OAKMONT INVESTMENTS, LLC ITS: GENERAL PARTNER BY: /S/ Daniel Asher --------------------------------------- Daniel Asher Manager, Oakmont Investments, LLC OAKMONT INVESTMENTS, LLC BY: /S/ Daniel Asher --------------------------------------- Daniel Asher, Manager /s/ Daniel Asher ------------------------------------------- DANIEL ASHER -----END PRIVACY-ENHANCED MESSAGE-----